Diagnosis and Treatment of Lung Cancer in the Setting of Interstitial Lung Disease

Published:September 02, 2022DOI:


      To read this article in full you will need to make a payment

      Purchase one-time access:

      Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online access
      One-time access price info
      • For academic or personal research use, select 'Academic and Personal'
      • For corporate R&D use, select 'Corporate R&D Professionals'

      Subscribers receive full online access to your subscription and archive of back issues up to and including 2002.

      Content published before 2002 is available via pay-per-view purchase only.


      Subscribe to Radiologic Clinics
      Already a print subscriber? Claim online access
      Already an online subscriber? Sign in
      Institutional Access: Sign in to ScienceDirect


      1. Key statistics for lung cancer. In: American cancer society.
        (Available at:) (Accessed January 15, 2022)
        • Whittaker Brown S.A.
        • Padilla M.
        • Mhango G.
        • et al.
        Outcomes of older patients with pulmonary fibrosis and non-small cell lung cancer.
        Ann Am Thorac Soc. 2019; 16: 1034-1040
        • Hartwig M.G.
        • D’Amico T.A.
        Thoracoscopic lobectomy: the gold standard for early-stage lung cancer?.
        Ann Thorac Surg. 2010; 89: S2098-S2101
        • Brown S.A.W.
        • Dobelle M.
        • Padilla M.
        • et al.
        Idiopathic pulmonary fibrosis and lung cancer. a systematic review and meta-analysis.
        Ann Am Thorac Soc. 2019; 16: 1041-1051
        • Joo S.
        • Kim D.K.
        • Sim H.J.
        • et al.
        Clinical results of sublobar resection versus lobectomy or more extensive resection for lung cancer patients with idiopathic pulmonary fibrosis.
        J Thorac Dis. 2016; 8: 977-984
        • Naccache J.M.
        • Gibiot Q.
        • Monnet I.
        • et al.
        Lung cancer and interstitial lung disease: a literature review.
        J Thorac Dis. 2018; 10: 3829-3844
        • Jung H.I.
        • Park J.S.
        • Lee M.Y.
        • et al.
        Prevalence of lung cancer in patients with interstitial lung disease is higher than in those with chronic obstructive pulmonary disease.
        Medicine (Baltimore). 2018; 97: e0071
        • Song M.J.
        • Kim D.J.
        • Paik H.C.
        • et al.
        Impact of idiopathic pulmonary fibrosis on recurrence after surgical treatment for stage I–III non-small cell lung cancer.
        PLoS One. 2020; 15: e0235126
        • Masai K.
        • Tsuta K.
        • Motoi N.
        • et al.
        Clinicopathological, immunohistochemical, and genetic features of primary lung adenocarcinoma occurring in the setting of usual interstitial pneumonia pattern.
        J Thorac Oncol. 2016; 11: 2141-2149
        • Yoon J.H.
        • Nouraie M.
        • Chen X.
        • et al.
        Characteristics of lung cancer among patients with idiopathic pulmonary fibrosis and interstitial lung disease – analysis of institutional and population data.
        Respir Res. 2018; 19: 195
        • Kim H.C.
        • Lee S.
        • Song J.W.
        Impact of idiopathic pulmonary fibrosis on clinical outcomes of lung cancer patients.
        Sci Rep. 2021; 11: 8312
        • Choi W.I.
        • Lee D.Y.
        • Choi H.G.
        • et al.
        Lung Cancer development and mortality in interstitial lung disease with and without connective tissue diseases: a five-year Nationwide population-based study.
        Respir Res. 2019; 20: 117
        • Ozawa Y.
        • Suda T.
        • Naito T.
        • et al.
        Cumulative incidence of and predictive factors for lung cancer in IPF.
        Respirology. 2009; 14: 723-728
        • Barczi E.
        • Nagy T.
        • Starobinski L.
        • et al.
        Impact of interstitial lung disease and simultaneous lung cancer on therapeutic possibilities and survival.
        Thorac Cancer. 2020; 11: 1911-1917
        • Sato T.
        • Watanabe A.
        • Kondo H.
        • et al.
        Long-term results and predictors of survival after surgical resection of patients with lung cancer and interstitial lung diseases.
        J Thorac Cardiovasc Surg. 2015; 149 (70.e1-2): 64-69
        • Ryerson Christopher
        Evaluation and management of lung cancer in patients with interstitial lung disease.
        in: King T. UpToDate. 2021 (Available at:) (Accessed September 12, 2021)
        • Nambiar A.M.
        • Walker C.M.
        • Sparks J.A.
        Monitoring and management of fibrosing interstitial lung diseases: a narrative review for practicing clinicians.
        Ther Adv Respir Dis. 2021; 15 (17534666211039772)
        • Tzouvelekis A.
        • Spagnolo P.
        • Bonella F.
        • et al.
        Patients with IPF and lung cancer: diagnosis and management.
        Lancet Respir Med. 2018; 6: 86-88
        • Lee K.J.
        • Chung M.P.
        • Kim Y.W.
        • et al.
        Prevalence, risk factors and survival of lung cancer in the idiopathic pulmonary fibrosis: Idiopathic pulmonary fibrosis with lung cancer.
        Thorac Cancer. 2012; 3: 150-155
        • Lloyd C.R.
        • Walsh S.L.F.
        • Hansell D.M.
        High-resolution CT of complications of idiopathic fibrotic lung disease.
        Br J Radiol. 2011; 84: 581-592
        • Oh S.Y.
        • Kim M.Y.
        • Kim J.E.
        • et al.
        Evolving early lung cancers detected during follow-up of idiopathic interstitial pneumonia: serial CT features.
        AJR Am J Roentgenol. 2015; 204: 1190-1196
        • Jeon T.Y.
        • Lee K.S.
        • Yi C.A.
        • et al.
        Incremental value of PET/CT over ct for mediastinal nodal staging of non–small cell lung cancer: comparison between patients with and without idiopathic pulmonary fibrosis.
        Am J Roentgenol. 2010; 195: 370-376
        • Bourgouin P.P.
        • Rodriguez K.J.
        • Fintelmann F.J.
        Image-guided percutaneous lung needle biopsy: how we do it.
        Tech Vasc Interv Radiol. 2021; 24: 100770
        • Fintelmann F.J.
        • Troschel F.M.
        • Kuklinski M.W.
        • et al.
        Safety and success of repeat lung needle biopsies in patients with epidermal growth factor receptor-mutant lung cancer.
        Oncologist. 2019; 24: 1570-1576
        • Shin Y.J.
        • Yun G.
        • Yoon S.H.
        • et al.
        Accuracy and complications of percutaneous transthoracic needle lung biopsy for the diagnosis of malignancy in patients with idiopathic pulmonary fibrosis.
        Eur Radiol. 2021; 31: 9000-9011
        • Green D.B.
        • Groner L.K.
        • Lee J.J.
        • et al.
        Overview of interventional pulmonology for radiologists.
        RadioGraphics. 2021; 41: 1916-1935
        • Navani N.
        • Nankivell M.
        • Lawrence D.R.
        • et al.
        Lung cancer diagnosis and staging with endobronchial ultrasound-guided transbronchial needle aspiration compared with conventional approaches: an open-label, pragmatic, randomised controlled trial.
        Lancet Respir Med. 2015; 3: 282-289
        • Gex G.
        • Pralong J.A.
        • Combescure C.
        • et al.
        Diagnostic yield and safety of electromagnetic navigation bronchoscopy for lung nodules: a systematic review and meta-analysis.
        Respir Int Rev Thorac Dis. 2014; 87: 165-176
        • Kawasaki H.
        • Nagai K.
        • Yoshida J.
        • et al.
        Postoperative morbidity, mortality, and survival in lung cancer associated with idiopathic pulmonary fibrosis.
        J Surg Oncol. 2002; 81: 33-37
        • Sato T.
        • Teramukai S.
        • Kondo H.
        • et al.
        Impact and predictors of acute exacerbation of interstitial lung diseases after pulmonary resection for lung cancer.
        J Thorac Cardiovasc Surg. 2014; 147: 1604-1611.e3
        • Ozawa Y.
        • Shibamoto Y.
        • Hiroshima M.
        • et al.
        Preoperative CT findings for predicting acute exacerbation of interstitial pneumonia after lung cancer surgery: a multicenter case-control study.
        Am J Roentgenol. 2021; 217: 859-869
        • Okamoto T.
        • Gotoh M.
        • Masuya D.
        • et al.
        Clinical analysis of interstitial pneumonia after surgery for lung cancer.
        Jpn J Thorac Cardiovasc Surg. 2004; 52: 323-329
        • Watanabe A.
        • Higami T.
        • Ohori S.
        • et al.
        Is lung cancer resection indicated in patients with idiopathic pulmonary fibrosis?.
        J Thorac Cardiovasc Surg. 2008; 136: 1357-1363.e1-2
        • Iwata T.
        • Yoshida S.
        • Fujiwara T.
        • et al.
        Effect of Perioperative Pirfenidone Treatment in Lung Cancer Patients With Idiopathic Pulmonary Fibrosis.
        Ann Thorac Surg. 2016; 102: 1905-1910
        • Chen H.
        • Senan S.
        • Nossent E.J.
        • et al.
        Treatment-related toxicity in patients with early-stage non-small cell lung cancer and coexisting interstitial lung disease: a systematic review.
        Int J Radiat Oncol. 2017; 98: 622-631
        • National Comprehensive Cancer Network
        Non-small cell lung cancer (Version 1.2022).
        (Available at:) (Accessed February 18, 2022)
        • Glick D.
        • Lyen S.
        • Kandel S.
        • et al.
        Impact of pretreatment interstitial lung disease on radiation pneumonitis and survival in patients treated with lung stereotactic body radiation therapy (SBRT).
        Clin Lung Cancer. 2018; 19: e219-e226
        • Onishi H.
        • Yamashita H.
        • Shioyama Y.
        • et al.
        stereotactic body radiation therapy for patients with pulmonary interstitial change: high incidence of fatal radiation pneumonitis in a retrospective multi-institutional study.
        Cancers. 2018; 10: 257
        • Okubo M.
        • Itonaga T.
        • Saito T.
        • et al.
        Predicting risk factors for radiation pneumonitis after stereotactic body radiation therapy for primary or metastatic lung tumours.
        Br J Radiol. 2017; 90: 20160508
        • Simone C.B.
        • Rengan R.
        The Use of Proton Therapy in the Treatment of Lung Cancers.
        Cancer J. 2014; 20: 427-432
        • Kim H.
        • Pyo H.
        • Noh J.M.
        • et al.
        Preliminary result of definitive radiotherapy in patients with non-small cell lung cancer who have underlying idiopathic pulmonary fibrosis: comparison between X-ray and proton therapy.
        Radiat Oncol. 2019; 14: 19
        • Ono T.
        • Hareyama M.
        • Nakamura T.
        • et al.
        The clinical results of proton beam therapy in patients with idiopathic pulmonary fibrosis: a single center experience.
        Radiat Oncol. 2016; 11: 56
        • Li F.
        • Liu H.
        • Wu H.
        • et al.
        Risk factors for radiation pneumonitis in lung cancer patients with subclinical interstitial lung disease after thoracic radiation therapy.
        Radiat Oncol. 2021; 16: 70
        • Castillo R.
        • Pham N.
        • Ansari S.
        • et al.
        Pre-radiotherapy FDG PET predicts radiation pneumonitis in lung cancer.
        Radiat Oncol Lond Engl. 2014; 9: 74
        • Murphy M.C.
        • Wrobel M.M.
        • Fisher D.A.
        • et al.
        Update on Image-Guided Thermal Lung Ablation: Society Guidelines, Therapeutic Alternatives, and Postablation Imaging Findings.
        AJR Am J Radiol. 2022; : 1-15
        • Kwan S.W.
        • Mortell K.E.
        • Talenfeld A.D.
        • et al.
        thermal ablation matches sublobar resection outcomes in older patients with early-stage non–small cell lung cancer.
        J Vasc Interv Radiol. 2014; 25: 1-9.e1
        • Zemlyak A.
        • Moore W.H.
        • Bilfinger T.V.
        Comparison of survival after sublobar resections and ablative therapies for stage I non−small cell lung cancer.
        J Am Coll Surg. 2010; 211: 68-72
        • Kashima M.
        • Yamakado K.
        • Takaki H.
        • et al.
        Complications after 1000 lung radiofrequency ablation sessions in 420 patients: a single center’s experiences.
        Am J Roentgenol. 2011; 197: W576-W580
        • Jiang B.
        • Mcclure M.A.
        • Chen T.
        • et al.
        Efficacy and safety of thermal ablation of lung malignancies: A Network meta-analysis.
        Ann Thorac Med. 2018; 13: 243-250
        • Ohtsuka T.
        • Asakura K.
        • Masai K.
        • et al.
        OA12.03 Percutaneous cryoablation for lung cancer patients for whom surgery or radiotherapy is contraindicated due to idiopathic pulmonary fibrosis.
        J Thorac Oncol. 2017; 12: S290
        • Kenmotsu H.
        • Naito T.
        • Kimura M.
        • et al.
        the risk of cytotoxic chemotherapy-related exacerbation of interstitial lung disease with lung cancer.
        J Thorac Oncol. 2011; 6: 1242-1246
        • Akaike K.
        • Saruwatari K.
        • Oda S.
        • et al.
        Predictive value of 18F-FDG PET/CT for acute exacerbation of interstitial lung disease in patients with lung cancer and interstitial lung disease treated with chemotherapy.
        Int J Clin Oncol. 2020; 25: 681-690
        • Kobayashi H.
        • Naito T.
        • Omae K.
        • et al.
        Impact of interstitial lung disease classification on the development of acute exacerbation of interstitial lung disease and prognosis in patients with stage iii non-small-cell lung cancer and interstitial lung disease treated with chemoradiotherapy.
        J Cancer. 2018; 9: 2054-2060
        • Goodman C.D.
        • Nijman S.F.M.
        • Senan S.
        • et al.
        A primer on interstitial lung disease and thoracic radiation.
        J Thorac Oncol. 2020; 15: 902-913
        • Wang G.X.
        • Kurra V.
        • Gainor J.F.
        • et al.
        immune checkpoint inhibitor cancer therapy: spectrum of imaging findings.
        Radiogr Rev Publ Radiol Soc N Am Inc. 2017; 37: 2132-2144
        • Su Q.
        • Zhu E.C.
        • Wu J Bo
        • et al.
        Risk of pneumonitis and pneumonia associated with immune checkpoint inhibitors for solid tumors: a systematic review and meta-analysis.
        Front Immunol. 2019; 10: 108
        • Dobre I.A.
        • Frank A.J.
        • D’Silva K.M.
        • et al.
        Outcomes of patients with interstitial lung disease receiving programmed cell death 1 inhibitors: a retrospective case series.
        Clin Lung Cancer. 2021; 22: e738-e744
        • Richeldi L.
        • du Bois R.M.
        • Raghu G.
        • et al.
        Efficacy and safety of nintedanib in idiopathic pulmonary fibrosis.
        N Engl J Med. 2014; 370: 2071-2082